← Leaderboards
Pradeep Tyagi
University Of Pittsburgh At Pittsburgh
$1,720,181
Attributed
$2,765,864
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $522.1K · FY2006–23$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,765,864 · 5
By mechanism
R01$1,617,962 · 2
R21$1,147,902 · 3
Top collaborators
- Michael B Chancellor5 shared
- Naoki Yoshimura5 shared
- Jodi Kathleen Maranchie1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Anthony John Kanai$13,693,260
- Timothy M. Bruns$3,981,645
- Naoki Yoshimura$12,168,895
- Michael B Chancellor$7,406,767
- Werner Schaefer$124,230
Others in their field
Top investigators on “Bladder”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- Scott J Hultgren · Washington University$37,336,079
- Walter John Curran · Thomas Jefferson University$37,227,688
- Norman Wolmark · Nsabp Foundation, Inc.$33,598,810
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$33,598,810
- Laurence N. Kolonel · University Of Hawaii At Manoa$30,101,767
Research focus
BladderAdverse EffectsPharmaceutical PreparationsMediatingUrotheliumIntravesicalRecurrenceNovel Therapeutic InterventionVoltageLiposomesCellsNovel TherapeuticsRattusAntibodiesImageUrineAcetylcholineRouteAfferent NeuronsBaseCholinergicMolecularSpinal Cord InjuryReceptor
Grant awards (11)
Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade$181,574
R21 · FY2023 · CA · contact PI
Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade$209,468
R21 · FY2022 · CA · contact PI
Virtual Histology of the Bladder Wall for Bladder Cancer Staging$326,485
R21 · FY2020 · CA
A Novel Combination Drug Treatment for Detrusor Hyperactivity with Impaired Contractile Function (DHIC)$195,625
R21 · FY2020 · AG · contact PI
A Novel Combination Drug Treatment for Detrusor Hyperactivity with Impaired Contractile Function (DHIC)$234,750
R21 · FY2019 · AG · contact PI
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder$308,809
R01 · FY2014 · DK · contact PI
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder$304,907
R01 · FY2013 · DK · contact PI
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder$322,918
R01 · FY2012 · DK · contact PI
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder$380,798
R01 · FY2011 · DK · contact PI
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder$6,229
R01 · FY2011 · DK · contact PI
Proteomic Characterization of IC Bladder$294,301
R01 · FY2006 · DK · contact PI